Impact of first-line infliximab on the pharmacokinetics of second-line vedolizumab in inflammatory bowel diseases

BACKGROUND: Very little is known about the impact of the wash-out period on the pharmacokinetics of a second-line biologic. OBJECTIVE: The objective of this article is to explore the impact of two different wash-out periods on the pharmacokinetics of vedolizumab and infliximab. METHODS: Patients swi...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:United European Gastroenterol J
Main Authors: Liefferinckx, Claire, Verstockt, Bram, Gils, Ann, Tops, Sophie, Van Moerkercke, Wouter, Vermeire, Severine, Franchimont, Denis
Formato: Artigo
Idioma:Inglês
Publicado: SAGE Publications 2019
Assuntos:
Original Articles
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6620879/
https://ncbi.nlm.nih.gov/pubmed/31316779
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2050640619841538
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares